Virax Biolabs(us:VRAX)
1.87
+6.86%
Updated on 2024-12-23
Open:1.70
Close:1.87
High:2.05
Low:1.69
Pre Close:1.75
Volume:382177.00
Amount:715965.31
Turnover:8.80%
Shares:4.34M
MarketCap:8.12M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-03-31 | 5 | 17460 | 0.74% | 1 | 1 | 3 |
| 2023-12-31 | 6 | 133508 | 7.37% | 2 | 1 | 2 |
| 2023-09-30 | 7 | 3351 | 0.02% | 3 | 0 | 3 |
| 2023-06-30 | 8 | 57338 | 0.37% | 3 | 0 | 5 |
| 2023-03-31 | 10 | 1643242 | 10.57% | 3 | 0 | 7 |
| 2022-12-31 | 11 | 184903 | 1.44% | 5 | 0 | 5 |
| 2022-09-30 | 6 | 58378 | 0.50% | 6 | 0 | 0 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Citadel Advisors Llc | 14785 | 0.63% | 14785 | |
| 2024-03-31 | Ubs Group Ag | 2575 | 0.11% | 1910 | 287.22% |
| 2024-03-31 | Wells Fargo & Company/Mn | 100 | 0.00% | -100 | -50.00% |
| 2024-03-31 | Armistice Capital, Llc | 0 | -121999 | ||
| 2024-03-31 | Virtu Financial Llc | 0 | -10644 | ||
| 2023-12-31 | Armistice Capital, Llc | 121999 | 6.73% | 121999 | |
| 2023-12-31 | Virtu Financial Llc | 10644 | 0.59% | 10644 | |
| 2023-12-31 | Ubs Group Ag | 665 | 0.04% | 650 | 4333.33% |
| 2023-12-31 | Wells Fargo & Company/Mn | 200 | 0.01% | 0 | |
| 2023-12-31 | Susquehanna International Group, Llp | 0 | -1500 |
About
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Address:20 North Audley Street
Website:http://www.viraxbiolabs.com
Market Movers